The CardiacSense: reliable cardiac and blood pressure monitoring

A wearable device measures cortisol in sweat

A new device attached to a smartphone could be the future of early cancer diagnosis

A new waterless toilet can detect biomarkers

Regular medical check-ups could be soon replaced by visits to the bathroom, thanks to the smart toilets, designed by Science Walden design team at the Ulsan National Institute of Science and Technology (UNIST). This smart toilet system is the latest version of the previous waterless energy-producing toilet system BeeVi Toilet, created as part of the Science Walden Project. At the heart of this Science Walden project is the Feces Standard Money (FSM). Their new, advanced BeeVi WALDEN 2.0 even features a built-in health screening system that could be used to analyze urine and other waste matter and inform users of their current wellbeing via a smartphone application.


A portable device for rapid and highly sensitive diagnostics

A portable and low-cost diagnostic device has been developed by the researchers at Ecole Polytechnique Fédérale de Lausanne. This microfluidic tool, which has been tested with Ebola (lat. Zaire ebolavirus), requires no bulky equipment. It is thus ideally suited for use in remote regions. Over the past several years, microfluidic devices have shown extraordinary potential in the area of diagnostics. They are composed of silicone rubber with minuscule channels the width of a hair. Microfluidic devices, and can rapidly detect a number of different biomarkers in very small quantities of blood (lat. Sanguis).


Patient-specific aptamer generation for noninvasive diagnosis of MRD

Minimal residual disease (MRD) is a leading complication of multiple myeloma, in which small amounts of cancerous cells remain after standard chemotherapy, resulting in relapse and often death. However, methods to detect minimal residual disease (MRD) are often invasive or give frequent false negatives. As such, there is a need for a simple, noninvasive method that detects patient-specific biomarkers of minimal residual disease to improve patient outcomes and survival. Therefore, a scientific group, led by Professor Qiao Lin at Columbia University, developed an innovative technology that is a microfluidic device that generates aptamers for individualized detection of minimal residual disease (MRD).


Getting electricity from the atmosphere

Smart bandages designed to monitor and tailor treatment for chronic wounds

Serious game aims to save lives of African-Caribbean men most at risk of prostate cancer

A low-cost wireless AI heart monitor

A cost-effective next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time has been developed by a Cambridge spinoff company, Cambridge Heartwear. The company's device, called Heartsense, includes a multiple lead ECG, oxygen sensing, temperature, and tracking device which can be comfortably worn by patients for early screening. Sensors are enclosed in a robust waterproof casing, and the data produced is far more sensitive than that from current single lead wearable devices, as the development team has used their knowledge of clinical anatomy and electrophysiology to place leads for maximal signal output.



An innovative safe and painless microneedle patch

Needle phobia is a common fear for both children and adults. However, with the microneedle patch invented by Chulalongkorn University Mechanical Engineering Professor, Assistant Professor, Dr Werayut Srituravanich, there may very well now be a quick and affordable solution for needle fear.  Through over 4 years of research, Dr Werayut has developed the microneedle - a small transdermal patch used for drug delivery that is low in cost and safe to use. This innovative microneedle patch is not the first of its kind, however, it is economical and takes less time to apply.


A retinal implant that is more effective against blindness

A new type of retinal implant for people who have become blind (lat. Caecitudo) due to the loss of photoreceptor cells in their retinas has been developed by the researchers at Ecole Polytechnique Fédérale de Lausanne. The implant partially restores their visual field and can significantly improve their quality of life. The retinal implants currently available consist of a grid of electrodes placed directly on the retina. The implants are wired to a pair of glasses and a camera and to a portable microcomputer. The camera captures images that enter the implantee’s field of vision and sends them to the computer, which turns them into electrical signals that it transmits to the electrodes. 


Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.